4.8 Review

Function of oncogenes in cancer development: a changing paradigm

期刊

EMBO JOURNAL
卷 32, 期 11, 页码 1502-1513

出版社

WILEY
DOI: 10.1038/emboj.2013.97

关键词

cancer stem cell; cancer therapy; mouse model; oncogenes; tumoural reprogramming

资金

  1. FEDER
  2. MICINN [SAF2012-32810]
  3. MEC OncoBIO Consolider-Ingenio [CSD2007-0017]
  4. NIH grant [R01 CA109335-04A1]
  5. ARIMMORA project (FP7-ENV, European Union Seventh Framework Program)
  6. proyecto en red de investigacion en celulas madre tumourales
  7. Obra Social Kutxa y Conserjeria de Sanidad de la Junta de Castilla y Leon
  8. institutional grant from the Fundacion Ramon Areces
  9. European Union FEDER program

向作者/读者索取更多资源

Tumour-associated oncogenes induce unscheduled proliferation as well as genomic and chromosomal instability. According to current models, therapeutic strategies that block oncogene activity are likely to selectively target tumour cells. However, recent evidences have revealed that oncogenes are only essential for the proliferation of some specific tumour cell types, but not all. Indeed, the latest studies of the interactions between the oncogene and its target cell have shown that oncogenes contribute to cancer development not only by inducing proliferation but also by developmental reprogramming of the epigenome. This provides the first evidence that tumorigenesis can be initiated by stem cell reprogramming, and uncovers a new role for oncogenes in the origin of cancer. Here we analyse these evidences and propose an updated model of oncogene function that can explain the full range of genotype-phenotype associations found in human cancer. Finally, we discuss how this vision opens new avenues for developing novel anti-cancer interventions.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据